Last reviewed · How we verify
Nephrosolid tablets
Nephrosolid tablets work by reducing inflammation in the kidneys.
Nephrosolid tablets work by reducing inflammation in the kidneys. Used for Chronic kidney disease, Nephrotic syndrome.
At a glance
| Generic name | Nephrosolid tablets |
|---|---|
| Sponsor | A. Vogel AG |
| Drug class | Anti-inflammatory |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | Phase 3 |
Mechanism of action
Nephrosolid tablets contain a proprietary blend of herbal extracts that have anti-inflammatory properties, which help to reduce kidney inflammation and improve kidney function.
Approved indications
- Chronic kidney disease
- Nephrotic syndrome
Common side effects
- Gastrointestinal upset
- Headache
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nephrosolid tablets CI brief — competitive landscape report
- Nephrosolid tablets updates RSS · CI watch RSS
- A. Vogel AG portfolio CI